|
Volumn 12, Issue 11, 2006, Pages 1232-
|
Reply to Challenges to the report of Nogo antibody effects in primates [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
NOGO A ANTIBODY;
UNCLASSIFIED DRUG;
PROTEIN ANTIBODY;
PROTEIN NOGO A ANTIBODY;
MYELIN PROTEIN;
PROTEIN NOGO;
ANIMAL EXPERIMENT;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
IMMUNOTHERAPY;
LETTER;
MONKEY;
NERVE FIBER REGENERATION;
NERVE SPROUTING;
NONHUMAN;
PRIORITY JOURNAL;
SPINAL CORD LESION;
COMPARATIVE STUDY;
DISEASE ASSOCIATION;
EXPERIMENTAL ANIMAL;
NECK INJURY;
NERVE REGENERATION;
OUTCOME ASSESSMENT;
PYRAMIDAL TRACT;
QUANTITATIVE ANALYSIS;
STATISTICAL SIGNIFICANCE;
ANIMAL;
IMMUNOLOGY;
NOTE;
PRIMATE;
PRIMATES;
ANIMALS;
ANTIBODIES;
MYELIN PROTEINS;
PRIMATES;
|
EID: 33750696326
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1106-1232a Document Type: Letter |
Times cited : (7)
|
References (1)
|